Naringin attenuates acute myocardial ischemia-reperfusion injury via miR- 126/GSK-3β/β-catenin signaling pathway
Acta Cirúrgica Brasileira · 2022 · 37 (1)
DOI: 10.1590/acb370102 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Cirúrgica Brasileira, 2022. Verfasst von Xiuhui Guo und 3 weiteren Autor:innen. Beteiligte Einrichtung: MD. Department of Price Office of Finance - The Second Hospital - Cheeloo College of Medicine - Shandong University - Shandong Province, China. Hauptthemen laut MEDLINE: Flavanones, Glycogen Synthase Kinase 3 beta, MicroRNAs, Myocardial Infarction. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- MD. Department of Price Office of Finance - The Second Hospital - Cheeloo College of Medicine - Shandong University - Shandong Province, China.
- MD. Department of Obstetrics - The Second Hospital - Cheeloo College of Medicine - Shandong University - Shandong Province, China.
- MD. Department of Ultrasonography - The Second Hospital - Cheeloo College of Medicine - Shandong University - Shandong Province, China.
Zitieren
APA
Guo, X., Ji, Q., Wu, M., & Ma, W. (2022). Naringin attenuates acute myocardial ischemia-reperfusion injury via miR- 126/GSK-3β/β-catenin signaling pathway. Acta Cirúrgica Brasileira, 37(1). https://doi.org/10.1590/acb370102
Vancouver
Guo X, Ji Q, Wu M, Ma W. Naringin attenuates acute myocardial ischemia-reperfusion injury via miR- 126/GSK-3β/β-catenin signaling pathway. Acta Cirúrgica Brasileira. 2022;37(1). doi:10.1590/acb370102
BibTeX
@article{Guo2022,
author = {Guo, Xiuhui and Ji, Qinghong and Wu, Mei and Ma, Weihong},
title = {Naringin attenuates acute myocardial ischemia-reperfusion injury via miR- 126/GSK-3β/β-catenin signaling pathway},
journal = {Acta Cirúrgica Brasileira},
year = {2022},
volume = {37},
number = {1},
doi = {10.1590/acb370102}
}
EUVIMED